Top Markets
#1 MowCat MowCat +369.83%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.68%
#3 SODAX SODAX +47.27%
#4 Cortex Cortex +34.03%
#5 OpenEden OpenEden +24.18%
#6 DexNet DexNet +23.19%
#7 Akedo Akedo +16.57%
#8 wojak wojak +16.21%
#9 Magma Finance Magma Finance +15.83%
#10 MANTRA MANTRA +15.75%
Coin of the day
MowCat MowCat
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Biotest AG Biotest AG

Biotest AG

BIO
Kedudukan dalam Saham #7311
Biotest AG is a German biopharmaceutical company focused on the global... Biotest AG is a German biopharmaceutical company focused on the global development, manufacturing, and commercialization of biological medications. The firm organizes its activities into the Therapy, Plasma & Services, and Other segments. Its product portfolio addresses critical needs in hematology, clinical immunology, and intensive care medicine. Among its offerings are treatments for hemophilia A (such as Haemoctin and Vihuma) and hemophilia B (like Haemonine), covering both acute care and prevention. Biotest also provides therapies for various viral infections, including cytomegalovirus (Cytotect CP), hepatitis B (Fovepta, Hepatect, Zutectra), and varicella zoster (Varitect). Additionally, its products, such as Intratect and IgG Next Generation, are utilized for primary and secondary immune deficiencies, autoimmune disorders, and certain neurological conditions. The company further supplies solutions to manage circulating blood volume (Albiomin, Biseko), address clotting factor deficiencies (Cofact, Fibrinogen), and combat serious infections like community-acquired pneumonia and COVID-19 (Trimodulin), as well as general bacterial infections (Pentaglobin). Established in 1946 as Biotest Serum-Institut GmbH, the company adopted its current name, Biotest Aktiengesellschaft, in 1986. Headquartered in Dreieich, Germany, Biotest Aktiengesellschaft has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
Harga Saham
$47.45
Disegerakkan terakhir: 2026-05-13
Modal Pasaran
$1.63B
Perubahan (1 hari)
2.04%
Perubahan (1 tahun)
3.15%
Negara
DE
Perdagangan Biotest AG (BIO)

Kategori

Healthcare
Sejarah harga saham bagi Biotest AG (BIO)
Harga penutupan tertinggi: $47.86 pada 2026-05-01

Harga penutupan terendah: $6.49 pada 1998-11-01
Sejarah harga saham Biotest AG dari 1998 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 4.97%
2025 -1.89%
2024 -6.52%
2023 1.79%
2022 -5.71%
2021 41.57%
2020 54.29%
2019 -25.81%
2018 8.86%
2017 57.83%
2016 -6.25%
2015 -48.27%
2014 5.79%
2013 52.48%
2012 28.11%
2011 -13.50%
2010 6.55%
2009 -15.37%
2008 22.41%
2007 46.70%
2006 31.41%
2005 82.28%
2004 76.04%
2003 68.97%
2002 -56.60%
2001 -19.56%
2000 3.02%
1999 -24.95%
1998 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.48%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.91 7.41%
CH